Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodies

Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodies

US Patent 10683356 · Granted Jun 16, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of dipeptide repeat proteins2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2024
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2024
Inhibition of dipeptide repeat proteins2024
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2023
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2023